UNDERVALUED CHINESE STOCKS

[BiotechValues]

On a purely fundamental basis/earnings growth/PE ratio/cash position, yes.

Not enough trading in it though. They need an IR firm and to attend some conferences- both things I've been told they'll be doing this year.

I bought CFSG in March of 2007 when it traded like LTUS- it was still OTC back then, and sometimes only traded 1,000 shares/day. Now it's NASDAQ and trades 200-300k shares/day on average.
Given the 120% income growth, low PE, and cash position of LTUS, I think it's just a matter of time before it rises to $2+.

Income for 2007 should be around .18/share, so the stock needs to double to get to a modest PE of 11.

Happy New Year!